4 Factors That Sent Teva Pharmaceutical Industries Ltd. Sliding 45% in 2016
Pharmaceutical | January 07, 2017
Shares of Teva Pharmaceutical Industries (NYSE: TEVA), an Israeli-based developer of branded and generic drugs, sank a mind-numbing 45% in 2016, according to data from S&P Global Market Intelligence. The reason for the drop can primarily be traced to four factors.